Anika Therapeutics Inc
F:AKP
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
A
|
Anika Therapeutics Inc
F:AKP
|
US |
|
A
|
Autozone Inc
XMUN:AZ5
|
US |
|
Mediobanca Banca di Credito Finanziario SpA
MIL:MB
|
IT |
|
Impala Platinum Holdings Ltd
OTC:IMPUY
|
ZA |
|
C
|
Cardinal Health Inc
DUS:CLH
|
US |
|
H
|
Healthpeak Properties Inc
F:HC5
|
US |
Wall St Price Targets
AKP Price Targets Summary
Anika Therapeutics Inc
According to Wall Street analysts, the average 1-year price target for AKP is 8.42 EUR with a low forecast of 8.34 EUR and a high forecast of 8.67 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is AKP's stock price target?
Price Target
8.42
EUR
According to Wall Street analysts, the average 1-year price target for AKP is 8.42 EUR with a low forecast of 8.34 EUR and a high forecast of 8.67 EUR.
What is the Revenue forecast for Anika Therapeutics Inc?
Projected CAGR
8%
Over the last 13 years, the compound annual growth rate for Revenue has been 4%. The projected CAGR for the next 3 years is 8%.
What is the Gross Profit forecast for Anika Therapeutics Inc?
Projected CAGR
6%
Over the last 13 years, the compound annual growth rate for Gross Profit has been 3%. The projected CAGR for the next 2 years is 6%.
